News

Below you will find links to various news.

For investor related and NASDAQ-regulated press releases, please go here.

Science Talk: Fast-tracking of a COVID-19 vaccine development

Join us for this Science Talk with Drs. Ali Salanti, Max M Søgaard, and Louise Leth Hefting on development of […]

ExpreS2ion is mentioned in Ingeniøren

Read full article here: https://ing.dk/artikel/danskere-vil-dyrke-coronavaccine-bananflueceller-232322

ExpreS2ion is mentioned in Nigerian Guardian

Read full article here: https://guardian.ng/interview/drug-shortage-imminent-if-coronavirus-epidemic-persists/

ExpreS2ion’s CSO Dr. Wian de Jongh to speak at the ISBiotech 8th Spring Meeting in Norfolk, Virginia, USA – March 5-7

ExpreS2ion Biotechnologies will be presenting at the ISBiotech 8th Spring Meeting taking place on March 5-7, 2018 in Norfolk, Virginia, […]

Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen

Expres2ion Biotechnologies is mentioned in the Swedish newspaper Affärstidningen Näringsliv, in the supplement section “Time to Unite – a Greater […]

Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry

ExpreS2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “ExpreS2ion-direktør efter […]

ExpreS2ion Biotechnologies Announces Research License Agreement with the University of Pennsylvania

Horsholm, Denmark, November 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry

Expres2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “Biotekselskab og […]

The Francis Crick Institute Renews the Research License Agreement with ExpreS2ion Biotechnologies

Horsholm, Denmark, June 26, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

ExpreS2ion’s Chief Science Officer, Dr. Wian De Jongh, to Speak at World Biopharm Forum 2017 in Oxford, UK – June 27

Horsholm, Denmark, June 21, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

ExpreS2ion’s Chief Executive Officer, Dr. Steen Klysner, Speaks at Investordagen in Aarhus, Denmark – June 13

Horsholm, Denmark, June 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen

Expres2ion Biotechnologies is mentioned in the Swedish newspaper Affärstidningen Näringsliv, in the supplement section “Time to Unite – a Greater […]

Interview with CEO Steen Klysner in Erhverv Nordsjælland

Expres2ion Biotechnologies is mentioned in the Danish newspaper Erhverv Nordsjælland. The article includes an interview with CEO Sten Klysner. The […]

ExpreS2ion’s Chief Scientific Officer, Dr. Wian de Jongh, to Speak at ISBiotech 7th Spring Meeting in Washington D.C. – March 6-8

Horsholm, Denmark, February 16, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

2020-10-12: https://news.cision.com/se/expres2ion-biotechnologies/r/biostock-expres2ion-skalar-upp-via-emission,c3212598

2020-10-06: https://news.cision.com/se/expres2ion-biotechnologies/r/biostock-expres2ion-storsatsar-pa-egna-vaccin,c3210908

2020-09-10: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-will-present-its-technology-platform-and-pipeline-at-several-key-events-in-september-and-,c3192286

2020-09-03: https://news.cision.com/expres2ion-biotechnologies/r/analysguiden-raises-its-target-price-for-expres2ion-to-24-sek-per-share,c3188075

2020-08-18: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-appoints-new-cfo,c3170265

2020-08-03: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-exercise-of-2017-warrant-program,c3163270

2020-07-17: https://us14.campaign-archive.com/?u=7a62af7c8c9f244ef950ab854&id=988aa59bd3

2020-07-17: https://news.cision.com/expres2ion-biotechnologies/r/strong-proof-of-concept-for-cross-strain-protective-flu-cvlp-vaccine-further-strengthens-confidence-,c3155745

2020-07-14: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-s-platform-to-be-used-in-a-novel-zika-vaccine-candidate,c3152394

2020-05-04: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-supporting-an-advantageous-covid-19-diagnostic-antibody-development-project,c3102671

2020-04-15: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-s-cso-dr--wian-de-jongh-co-signs-who-sanctioned-statement-from-83-covid-19-vaccine-resear,c3088606

2020-03-20: https://us14.campaign-archive.com/?u=7a62af7c8c9f244ef950ab854&id=b3518c858c

2020-03-16: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-will-present-its-expres2-platform-and-pipeline-at-several-key-events-in-march-and-april-2,c3050755

2020-03-05: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-will-present-its-expres2-platform-and-pipeline-at-several-key-events-in-march-and-april-2,c3050755

2020-01-23: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-s-ceo-in-interview-on-2019-and-the-company-s-new-way-forward-with-a-stronger-pipeline-foc,c3015046

2020-01-21: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-is-streamlining-its-market-communication-with-english-as-primary-language,c3012218